Dr. Mark Agulnik
- Gender: Male
- Experience: 23 years
- Graduation year: 1998
- Sole propriator: No
Dr. Mark Agulnik MD
Oncologist
He is located at 675 N St Clair St in Chicago, IL 60611. Can help patients with the following: Cancer, Carcinoid Tumor, Glioma, Hodgkin's Disease, Lung Cancer, Stomach Cancer. Appointment can be made via the phone number (312) 695-0990. He also has a website where you can get more information. The website can be found at https://www.nm.org/doctors/1164448734/Mark-Agulnik-MD?utm_source=yext&utm_medium=other%20physician&utm_campaign=online%20listings. He is affiliated with 4 practices and 3 hospitals.
Conditions treated
Dr. Mark Agulnik, being an oncologist, treats the following conditions. Please be advised that this list may not be complete. For the full list of conditions treated, consult directly with Dr. Mark Agulnik.
- Anal Cancer
- Basal Cell Carcinoma
- Bile Duct Cancer
- Bladder Cancer
- Bone Cancer
- Brain Cancer
- Breast Cancer
- Cancer
- Carcinoid Tumor
- Carcinoma
- Cervical Cancer
- Colon Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Glioma
- Head and Neck Cancer
- Hodgkin's Disease
- Kidney Cancer
- Larynx Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Melanoma
- Mesothelioma
- Nasopharyngeal Cancer
- Neoplasm
- Neuroblastoma
- Non-Hodgkin's Lymphoma (NHL)
- Oral Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Penis Cancer
- Pheochromocytoma (PCC)
- Polycythemia
- Prostate Cancer
- Retinoblastoma
- Salivary Gland Cancer
- Sarcoma
- Skin Cancer
- Stomach Cancer
- Testicular Cancer
- Thymoma
- Thyroid Cancer
- Urethral Cancer
- Uterine Cancer
- Vaginal Cancer
Procedures Performed by Dr. Mark Agulnik
Insurances Accepted by Dr. Mark Agulnik
- Medicare
Payments received
Drug payment
| Janssen | $70629 |
| Novartis | $67109 |
| Eli Lilly And Company | $45729 |
Other
| Promotional Speaking or Service | $139126 |
| Consulting | $107233 |
| Travel and Lodging | $30898 |
| Other | $19860 |
| Food and Beverage | $8914 |
Studies
Graduated in 1998Other ways to reach out
- Website: https://www.nm.org/doctors/1164448734/Mark-Agulnik-MD?utm_source=yext&utm_medium=other%20physician&utm_campaign=online%20listings
- Facebook: https://www.facebook.com/pages/Mark-Agulnik-MD/226760907700531
Affiliated practices
Affiliated hospitals
Looking for more Oncologists?
Out of the 88 oncologists in this region, here are 10 randomly selected ones for you to explore.
- Gender: Female
- Address: Arkes Pavilion, Ste 850 676 N St Clair St Chicago, 60611, IL
- Gender: Female
- Address: Arkes Pavilion, Ste 800 676 N St Clair St Chicago, 60611, IL
- Gender: Female
- Address: Prentice Women's Hospital, Ste 4-420 250 E Superior St Chicago, 60611, IL
- Gender: Male
- Address: 251 East Huron Street Chicago, 60611, IL
- Gender: Female
- Address: Arkes Pavilion, Ste 2140 676 N St Clair St Chicago, 60611, IL
- Gender: Female
- Address: Prentice Women's Hospital, Ste 5-2261 250 E Superior St Chicago, 60611, IL
- Gender: Female
- Address: Galter Pavilion, 4th Flr 201 E Huron St Chicago, 60611, IL
- Gender: Female
- Address: Galter Pavilion, Ste 21-100 675 N St Clair St Chicago, 60611, IL
- Gender: Male
- Address: Robert H Lurie Medical Reseach Center, Ste 5-105 303 E Superior St Chicago, 60611, IL
- Gender: Male
- Address: Galter 21-100 675 North Saint Clair Street Chicago, 60611, IL
Questions & Answers
Has Dr. Mark Agulnik affiliation with hospitals?
Dr. Mark Agulnik is affiliated with NORTHWESTERN LAKE FOREST HOSPITAL. For the full list of hospitals see this list.
Does Dr. Mark Agulnik have affiliation with practices?
Dr. Mark Agulnik is affiliated with Northwestern Medical Group. For the full list of practices see this list.
What conditions does Dr. Mark Agulnik treat?
Dr. Mark Agulnik provides treatment for Cancer, Carcinoid Tumor, Glioma, Hodgkin's Disease, Lung Cancer, Stomach Cancer. For the full list see this list.
Where can you meet with Dr. Mark Agulnik?
Dr. Mark Agulnik's office is located at 675 N St Clair St in Chicago, IL 60611.
Does Dr. Mark Agulnik accept patients with Medicare?
Yes, Dr. Mark Agulnik accepts patients with Medicare.